Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

Armata Pharmaceuticals (ARMP) Return on Equity (2016 - 2018)

Armata Pharmaceuticals (ARMP) has disclosed Return on Equity for 5 consecutive years, with 0.41% as the latest value for Q3 2018.

  • Quarterly Return on Equity rose 105.0% to 0.41% in Q3 2018 from the year-ago period, while the trailing twelve-month figure was 0.41% through Sep 2018, up 105.0% year-over-year, with the annual reading at 0.33% for FY2017, 78.0% up from the prior year.
  • Return on Equity hit 0.41% in Q3 2018 for Armata Pharmaceuticals, down from 0.16% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 3.37% in Q3 2014 to a low of 79.08% in Q1 2015.
  • Historically, Return on Equity has averaged 4.95% across 5 years, with a median of 0.74% in 2015.
  • Biggest five-year swings in Return on Equity: plummeted -7987bps in 2015 and later surged 7794bps in 2016.
  • Year by year, Return on Equity stood at 5.86% in 2014, then skyrocketed by 87bps to 0.74% in 2015, then plummeted by -40bps to 1.03% in 2016, then skyrocketed by 67bps to 0.34% in 2017, then dropped by -21bps to 0.41% in 2018.
  • Business Quant data shows Return on Equity for ARMP at 0.41% in Q3 2018, 0.16% in Q2 2018, and 0.28% in Q1 2018.